Production (Stage)
Microbix Biosystems Inc.
MBX.TO
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -14.07% | -6.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.07% | -6.43% | |||
| Cost of Revenue | -8.20% | -21.48% | |||
| Gross Profit | -17.65% | 5.97% | |||
| SG&A Expenses | 10.81% | -1.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.07% | -11.45% | |||
| Operating Income | -82.03% | 32.99% | |||
| Income Before Tax | -97.65% | 41.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -97.65% | 89.65% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -97.65% | 89.65% | |||
| EBIT | -82.03% | 32.99% | |||
| EBITDA | -55.40% | 25.32% | |||
| EPS Basic | -97.78% | 87.50% | |||
| Normalized Basic EPS | -96.43% | 12.00% | |||
| EPS Diluted | -97.67% | 79.17% | |||
| Normalized Diluted EPS | -96.43% | 12.00% | |||
| Average Basic Shares Outstanding | 3.66% | -1.03% | |||
| Average Diluted Shares Outstanding | 3.74% | -1.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||